Reporting Anthony Silva
BOSTON (CBS) – Pfizer has dramatically increased its commitment to Cambridge with the groundbreaking of the company’s new research center in Kendall Square.
Pfizer is moving its cardiovascular, metabolic and neuroscience research to the site, according to Mikael Dolsten, President of Pfizer Worldwide Research & Development.
400 researchers will be working at the new facility, working on new therapies for diabetes, chronic kidney disease, dementia and autism.
WBZ NewsRadio 1030′s Anthony Silva reports